Comprehensive analysis to identify the RP11–478C19.2/ E2F7 axis as a novel biomarker for treatment decisions in clear cell renal cell carcinoma

Comprehensive analysis to identify the RP11–478C19.2/ E2F7 axis as a novel biomarker for treatment decisions in clear cell renal cell carcinoma

Clear cell renal cell carcinoma (ccRCC), accounting for 70–80% of all renal cell carcinomas, is a common malignancy. Survival rates decrease significantly in patients with advanced and metastatic ccRCC. Furthermore, ccRCC is less responsive to radiation and chemotherapy than other cancers. Therefore...

Full description

Bibliographic Details
Main Authors: Kai Zeng, Guoda Song, Bingliang Chen, Xintao Gao, Chaofan Liu, Jianping Miao, Yajun Ruan, Yang Luan, Xin Chen, Jihong Liu, Qinyu Li, Bo Liu
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:Translational Oncology
Subjects:
Competing endogenous RNAs
E2F7
Immune infiltration analysis
ccRCC
Treatment decision
Pan-cancer analysis
Online Access:http://www.sciencedirect.com/science/article/pii/S193652332200184X

Internet

http://www.sciencedirect.com/science/article/pii/S193652332200184X

Similar Items